Stem cell clinic for 4 year old

Cambridge Times

CAMBRIDGE The courageous fight of four-year-old Katie Herron is continuing at Torontos SickKids where she continues to undergo chemotherapy in hopes that a stem cell match can be found for a life-saving transplant.

Here in Cambridge, friends and family members are spreading the message for Katies Kure, in preparation for a stem cell donor clinic next Saturday, Feb. 22, at the Cambridge Sports Park.

There are now over 1,000 people going on our Facebook page (Katies Kure) with a great number of people registering online with onematch.ca that are unable to attend the actual donor drive, said her mother, Anne Hodgkinson, in an email.

We are absolutely overwhelmed with the support we are receiving from the community. Support not just for Katie and our family, but support in helping us get the information on stem cell donation out there.

Parents at Coronation Public School where Katie started junior kindergarten in September have distributed flyers across the city along with pink and green stars. Green represents stem cell donation and pink, Katies favourite colour, represents her journey.

Katie enjoys seeing pictures of all the stars put up around Cambridge, and it is a wonderful feeling for her to know that there are so many people thinking and praying for her back home, her mother says.

The youngsters mettle has been tested in recent weeks.

Last Thursday, she and her family were still in Hamilton at McMaster Childrens Hospital awaiting an MRI and other sedated testing for a critical bacterial infection shes fighting. Just after 11 a.m., they were given the news that SickKids had a bed available and Katie would be moved that day.

According to her mother, the whole ordeal has left Katie fragile, emotionally as well as physically. Shes still on a feeding tube, unable to walk, but is now undergoing physiotherapy, hoping to get her dancing feet back.

Excerpt from:
Stem cell clinic for 4 year old

Missouri House approves conscience rights bill for third time

JEFFERSON CITY Medical workers would be protected if they refused to participate in procedures such as abortions, fertility treatments or stem-cell research under a bill given initial approval by the Missouri House.

House Speaker Tim Jones, R-Eureka, said his bill protected the conscience rights of workers who did not want to provide specific, limited procedures that violated their religious beliefs. He said it also protected patients from having someone distracted while treating them.

This is good for workers in giving them more rights. This is good for patients, Jones said. Do you want that person taking care of you who is not 110 percent invested in what theyre doing and is sitting there wondering if theyre violating their religious beliefs?

The bill would prohibit retaliation from employers if an employee gave reasonable notice that they didnt want to participate in specific procedures. Jones said he had revised the bill from previous years to include exceptions for emergency situations.

The procedures listed in the bill include abortion, abortion-inducing drugs, contraception, reproductive assistance, human stem-cell research, human cloning, non-medically necessary sterilization and fetal tissue research.

Besides employees, the bill also protects institutions from being required to provide any procedure that violates its conscience, which would be determined from its guidelines and mission statement. The definitions in the bill include protections for refusing to refer patients for the specific procedures listed.

Opponents of the bill said it would interfere with womens access to medical services and was government intrusion into health care. Rep. Stacey Newman, D-St. Louis, said the bill specifically targeted procedures women have come to expect and rely on.

This is this body trying to put themselves in our gynecology offices telling our doctors exactly what they can and cant do, Newman said. "This is one more vagina-specific bill in an election year."

Jones said that the intent of the bill was solely to protect workers and their religious freedom under the First Amendment. He said Newman had brought political vitriol into the debate and said that if the other side really thought the government shouldnt be involved in health care, then they should help dismantle the presidents health care law.

This is simply codifying and giving greater freedom and more rights to institutions that do not want to provide certain services, Jones said.

Continue reading here:
Missouri House approves conscience rights bill for third time

Stem Cells -Medical News Today

knowledge center home stem cell research all about stem cells what are stem cells?

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources:

Both types are generally characterized by their potency, or potential to differentiate into different cell types (such as skin, muscle, bone, etc.).

Adult or somatic stem cells exist throughout the body after embryonic development and are found inside of different types of tissue. These stem cells have been found in tissues such as the brain, bone marrow, blood, blood vessels, skeletal muscles, skin, and the liver. They remain in a quiescent or non-dividing state for years until activated by disease or tissue injury.

Adult stem cells can divide or self-renew indefinitely, enabling them to generate a range of cell types from the originating organ or even regenerate the entire original organ. It is generally thought that adult stem cells are limited in their ability to differentiate based on their tissue of origin, but there is some evidence to suggest that they can differentiate to become other cell types.

Embryonic stem cells are derived from a four- or five-day-old human embryo that is in the blastocyst phase of development. The embryos are usually extras that have been created in IVF (in vitro fertilization) clinics where several eggs are fertilized in a test tube, but only one is implanted into a woman.

Sexual reproduction begins when a male's sperm fertilizes a female's ovum (egg) to form a single cell called a zygote. The single zygote cell then begins a series of divisions, forming 2, 4, 8, 16 cells, etc. After four to six days - before implantation in the uterus - this mass of cells is called a blastocyst. The blastocyst consists of an inner cell mass (embryoblast) and an outer cell mass (trophoblast). The outer cell mass becomes part of the placenta, and the inner cell mass is the group of cells that will differentiate to become all the structures of an adult organism. This latter mass is the source of embryonic stem cells - totipotent cells (cells with total potential to develop into any cell in the body).

In a normal pregnancy, the blastocyst stage continues until implantation of the embryo in the uterus, at which point the embryo is referred to as a fetus. This usually occurs by the end of the 10th week of gestation after all major organs of the body have been created.

However, when extracting embryonic stem cells, the blastocyst stage signals when to isolate stem cells by placing the "inner cell mass" of the blastocyst into a culture dish containing a nutrient-rich broth. Lacking the necessary stimulation to differentiate, they begin to divide and replicate while maintaining their ability to become any cell type in the human body. Eventually, these undifferentiated cells can be stimulated to create specialized cells.

Stem cells are either extracted from adult tissue or from a dividing zygote in a culture dish. Once extracted, scientists place the cells in a controlled culture that prohibits them from further specializing or differentiating but usually allows them to divide and replicate. The process of growing large numbers of embryonic stem cells has been easier than growing large numbers of adult stem cells, but progress is being made for both cell types.

Read the original here:
Stem Cells -Medical News Today

Director of Women’s Guild Lung Institute Awarded Stem Cell …

Screening For Early-Stage Lung Cancer Detection - Robert McKenna Jr., MD, Cedars-Sinai

Cedars-Sinai Medical Director of Thoracic Surgery and Trauma, and Co-Director, Women's Guild Lung Institute discusses the need for more screen for early-stag...

Regenerating heart tissue with stem cell therapy at the Board of Governors Heart Stem Cell Center at Cedars-Sinai Medical Center. http://www.cedars-sinai.edu...

A patient's perspective.

Cedars-Sinai Medical Director of Thoracic Surgery and Trauma, and Co-Director, Women's Guild Lung Institute discusses the many treatment options available fo...

The Nov. 10, 2013, Run for Her 5K Run and Friendship Walk brought together more than 5,500 registrants, volunteers, and Sleepwalkers Around the World who raised more than $880,000 for ovarian cancer research and awareness. Help keep the momentum going! Support the efforts of the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute as they fight to end cancer as a threat to women. More on Run for Her at their website: http://runforher.com Make a Gift to Support Ovarian Cancer Research and Awareness by visiting: http://runforher.kintera.org/faf/donorReg/donorPledge.asp?supId=0&ievent=1057689&lis=1 Learn more about the Women's Cancer Program by visiting: http://www.cedars-sinai.edu/Patients/Programs-and-Services/Womens-Cancer-Program/index.aspx Follow Run for Her on Facebook at: https://www.facebook.com/runforher Follow Run for Her on Twitter at: https://twitter.com/runforher

The Cedars-Sinai Medical Center honored Bob Barth at their 2011 Board of Governors Gala. Jankovic Productions is a Los Angeles-based video production company...

Sports Spectacular Fellowship Endowment supports the training of five research Fellows in various medical fields at Cedars-Sinai Medical Center. http://www.s...

As part of a Special Briefing for News Media at The Paley Center for Media in New York , hosted by Mayo Clinic's Dr. Sharonne Hayes, in conjunction with Nati...

Accurately diagnosing and treating complex heart valve disease requires experienced and highly-skilled physicians employing the latest technology to achieve ...

More here:
Director of Women's Guild Lung Institute Awarded Stem Cell ...

Scientists discover pre-leukemic stem cell at root of cancer

;

Dr. John Dick, a senior scientist at Princess Margaret Cancer Centre in Toronto, is shown in a handout photo.

TORONTO Canadian researchers have discovered a pre-leukemic stem cell that may be at the root of acute myeloid leukemia and also be the bad actor that evades chemotherapy and triggers a relapse in patients who have gone into remission.

Acute myeloid leukemia, or AML, is a rapidly progressing cancer of the blood and bone marrow that affects myeloid cells, which normally develop into mature red and white blood cells and platelets.

Leukemia develops when blood stem cells in the bone marrow make abnormal blood cells, which over time crowd out normal blood cells, affecting their ability to function as they should.

READ MORE:Could this new therapy kill cancer? Canadian doc thinks so

In a paper published online Wednesday in the journal Nature, researchers led by John Dick of Princess Margaret Cancer Centre in Toronto report on the discovery of a pre-leukemic stem cell the forerunner to leukemia stem cells that give rise to the disease.

A leukemia stem cell can lie dormant and theyre the ones that will sustain the growth of the leukemia, Dick said in an interview. The pre-leukemic guys are basically the ancestors that are on their way to becoming leukemia and becoming leukemic stem cells.

Dicks lab was the first to identify the existence of leukemia stem cells, in 1994, followed by the discovery of colon cancer stem cells in 2007.

Teasing out pre-leukemic stem cells from the blood of AML patients based on samples taken at diagnosis, after chemotherapy-induced remission, and then following recurrence advances the understanding of the genetic changes a normal cell has to go through before it turns into AML.

Here is the original post:
Scientists discover pre-leukemic stem cell at root of cancer

Miami Stem Cell Treatment Center Educational Seminar …

15:00 EST 12 Feb 2014 | PR Web

Join Miami Stem Cell Treatment Center on an exciting educational seminar focusing on how adipose-derived stem cells have been shown to have a preferred differentiation capability, have a minimal and virtually painless ease of extraction, and have been scientifically proven to have strong immuno-modulatory effects.

Boca Raton, FL (PRWEB) February 12, 2014

The Miami Stem Cell Treatment Center, PC, located in Miami, Ft. Lauderdale, and Boca Raton, Florida, announces a series of free public seminars on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief, and, Dr. Nia Smyrniotis, Medical Director.

The seminars will be held on February 16th and March 2nd. On February 16th, the seminar will be held at the Marriott Boca Raton, at Boca Center, 5150 Town Center Circle, Boca Raton, Florida 33486, at 2pm; and on March 2nd at the Hampton Inn Fort Lauderdale Downtown, 250 N. Andrews Blvd., Fort Lauderdale, Florida 33301, at 2pm. You can also join Miami Stem Cell Treatment Center at the Health and Wellness Experience Expo presented by WPEC Channel 12 and the Sun-Sentinel on March 1st at Mizner Park Amphitheater, Boca Raton, Florida from 10am-5pm. No reservations required.

At the Miami Stem Cell Treatment Center, utilizing investigational protocols, adult adipose derived stem cells (ADSCs) can be deployed to improve patients quality of life with a number of degenerative conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (also called stromal vascular fraction (SVF)). Adipose tissue is exceptionally abundant in ADSCs. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctors office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.

ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the bodys damaged cells. The Miami Stem Cell Treatment Center only uses autologous stem cells from a person's own fat no embryonic stem cells are used. Our current areas of study include: Heart Failure, Emphysema, COPD, Asthma, Parkinsons Disease, Stroke, Multiple Sclerosis, and orthopedic joint injections. For more information, or if someone thinks they may be a candidate for one of the stem cell protocols offered by Miami Stem Cell Treatment Center, they may contact Dr. Nia or Dr. Gionis directly at (561) 331-2999, or see a complete list of the Centers study areas at: http://www.MiamiStemCellsUSA.com.

About Miami Stem Cell Treatment Center:

The Miami Stem Cell Treatment Center is an affiliate of the Irvine Stem Cell Treatment Center (Irvine, California) and the Cell Surgical Network (CSN). We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patients own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Miami Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Research Protections; and the study is registered with http://www.Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information contact: Miami(at)MiamiStemCellsUSA(dot)com or visit our website: http://www.MiamiStemCellsUSA.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/February/2014/prweb11578607.htm

See more here:
Miami Stem Cell Treatment Center Educational Seminar ...